KATHLEEN LUTZ: Open Payments
NPI 1306930235 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,413 in 8 payments from 5 companies in 2025. Trend: 2023 $4,474 · 2024 $6,416 · 2025 $3,413
Consulting: $1,971Speaker / faculty: $1,140Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $1,317 |
| GlaxoSmithKline, LLC. | 1 | $1,236 |
| Genmab U.S., Inc. | 1 | $735 |
| Merck Sharp & Dohme LLC | 1 | $102 |
| Verastem, Inc. | 1 | $24 |
Products named: Epkinly, KEYTRUDA, AVMAPKI FAKZYNJA CO-PACK.
Industry payments across NY — which companies pay providers there.
